{"database": "openregs", "table": "documents", "rows": [["FDA-2009-Q-0301-0020", "FDA", "FDA-2009-Q-0301", "FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 25, 2011 - Letter", "Other", "LET-Letter", "2011-06-02T04:00:00Z", 2011, 6, "2011-06-02T04:00:00Z", null, "2013-08-11T04:46:04Z", null, 0, 0, "0900006480e34a14"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2009-Q-0301-0020"], "units": {}, "query_ms": 0.33471500501036644, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}